Prothena reported $-37961000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -112.57M 69.67M
Agios Pharmaceuticals AGIO:US $ -94.77M 3.81M
Akebia Therapeutics AKBA:US $ -62.42M 8.26M
Alnylam Pharmaceuticals ALNY:US $ -239.36M 20.95M
Amgen AMGN:US $ 2727M 56M
Biogen BIIB:US $ 903.4M 316.6M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Bluebird Bio BLUE:US $ -122.15M 10.09M
Exelixis EXEL:US $ 85.23M 32.79M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.11M 13.62M
IONIS PHARMACEUT IONS:US $ -64M 289M
Macrogenics MGNX:US $ -66.44M 8.42M
Nektar Therapeutics NKTR:US $ -90.27M 55.38M
Neurocrine Biosciences NBIX:US $ 21.4M 35.2M
Prothena PRTA:US $ -37.96M 4.86M
Regeneron Pharmaceuticals REGN:US $ 1119.1M 1986M
Seattle Genetics SGEN:US $ -135.24M 41.73M
Ultragenyx Pharmaceutical RARE:US $ -151.76M 29.32M
Vital Therapies VTL:US $ -20.81M 0.38M
Xoma XOMA:US $ -2.28M 32.22M
YTE INCY:US $ 172.84M 1.75M